Boehringer Ingelheim India Announces Partnership with Alivira Animal Health Limited
BusinessWire India
Mumbai (Maharashtra) [India], January 23: Boehringer Ingelheim India Private Limited has entered into an agreement with Alivira Animal Health Limited (a fully owned subsidiary of Viyash Scientific Limited) for the distribution and promotion of its companion animal products portfolio in India. This partnership will leverage the growth opportunities in Indian pet healthcare market that is driven by increased pet ownership, awareness of preventive care and growing emphasis on animal well-being in India.
He further adds, "Our portfolio continues to be built on high-quality products, supported by a robust and advancing pipeline, ensuring sustainable growth, strong governance, and consistent delivery for our customers. Together with Alivira Animal Health Limited, we can improve access, and responsiveness while preserving a clear strategy and brand experience to support the future growth of our companion animal business."
Dr. Haribabu Bodepudi, MD & Group CEO - Viyash Scientific Limited, said, "This represents an important milestone in Viyash Scientific's journey to become a key player in the companion animal segment. India offers tremendous opportunities for innovative medicines which cater to the medical needs of our pets. Driving access to high quality solutions for our pets in urban and rural India is at the heart of this partnership. Alivira's extensive geographical reach and on-ground capabilities, combined with Boehringer Ingelheim's differentiated companion animal product portfolio strengthens our ability to serve veterinarians and pet parents across India effectively."
Next Story